The ATS 2026 International Conference offers a robust scientific program highlighting cutting-edge advancements in pulmonary, critical care, and sleep medicine. This includes several Postgraduate Courses, Scientific Symposia, and Meet the Expert sessions addressing new developments and considerations in bronchiectasis and COPD, as listed below. A curated list of clinical and scientific sessions related to these topics is also available on the ATS365 platform. For more information on these and other sessions to be presented May 15–20 in Orlando, Fla., visit the online Advance Program.
- A101 COPD BIOMARKERS AND PHENOTYPING: MULTI-OMIC INSIGHTS, AI-DRIVEN DISCOVERY, AND CLINICAL IMPLICATIONS
- A106 YOU’VE GOT A FRIEND IN ME: BASIC, GENETIC, AND OMICS RESEARCH TO ADVANCE CHILDREN’S RESPIRATORY HEALTH
- A12 DO NO HARM, UNLESS THE AI SAYS OTHERWISE – AI ETHICS, A PRO/CON
- A16 COPD CRYSTAL BALL: LIFE-COURSE RISK FACTORS AND ADVANCED PREDICTIVE MODELS
- A18 THE AIR WE SHARE: POLLUTION, PULMONARY HEALTH, AND POLICY PERSPECTIVES
- A20 A PICTURE PAINTS A THOUSAND WORDS: IMAGING PULMONARY STRUCTURE AND FUNCTION
- A23 MORE THAN INHALERS: DETERMINANTS OF COPD CARE AND OUTCOMES
- A24 ALGORITHMS IN ACTION: APPLICATIONS OF ARTIFICIAL INTELLIGENCE ACROSS PULMONARY DISEASES
- A27 PEDIATRIC PULMONARY RESEARCH IN GLOBAL HEALTH AND UNDERSERVED POPULATIONS: IT’S A SMALL WORLD
- A29 PHYSICAL ACTIVITY, EXERCISE AND PULMONARY REHABILITATION FROM AROUND THE GLOBE
- A2 VISUALIZING THE TARGET: IMAGE-BASED MULTIMODAL PROFILING OF MICRO AND MACROENVIRONMENT IN LUNG DISEASE
- A33 FROM THE DARK SIDE TO THE LUNG SIDE: THE EPIC BATTLE AGAINST ARDS AND INFECTION
- A34 CHARTING THE UNSEEN TRAILS LEADING TO COPD
- A44 NEXT-GENERATION COPD CARE: TOOLS, TEAMS, AND TECHNOLOGY
- A55 OPTIMIZING VENTILATORY SUPPORT ACROSS THE SPECTRUM OF ACUTE RESPIRATORY FAILURE
- A58 LARGE-SCALE ANALYSES SHAPING THE FUTURE OF RESPIRATORY MEDICINE
- A72 CASE REPORTS FROM THE PULMONARY REHABILITATION ASSEMBLY
- A73 NOVEL MOLECULAR DETERMINANTS OF COPD AND LUNG CANCER PATHOGENESIS
- A76 INTERROGATING NOVEL MECHANISMS IN CHRONIC AIRWAY DISEASE
- A78 CASE REPORTS IN LUNG STRUCTURE AND FUNCTION I
- A80-2 FROM CELL CIRCUITS TO SCREENING STRATEGIES: UNCOVERING NOVEL MOLECULAR MECHANISMS AND ACCELERATING LUNG CANCER SCREENING IMPLEMENTATION
- A84 PRISM, GOLD 0, AND PRE-COPD: USEFUL CONCEPTS OR DIAGNOSTIC OVERREACH?
- A87 YOU BREATHE WHAT YOU EAT – EFFECTS OF NUTRITION ON LUNG HEALTH AND DISEASE
- A89 REDEFINING CARE: STRATEGIES FOR EFFECTIVE PATIENT-CENTERED MANAGEMENT ACROSS THE CONTINUUM IN SERIOUS RESPIRATORY ILLNESS
- A8 THE WOUNDED LUNG: CELLULAR STRESS, INFLAMMATION AND CARCINOGENESIS
- A90 ONE AIRWAY, MANY OUTCOMES: RETHINKING ASTHMA AND COPD ACROSS THE LIFESPAN
- A94 CARE WITHOUT BORDERS: PULMONARY HEALTH IN COMMUNITIES AROUND THE WORLD
- A97 PRECISION SEPSIS: HOST-RESPONSE PHENOTYPES AND TARGETED THERAPEUTIC PATHWAYS
- A99 DIFFERENT DELIVERY AND NEW POPULATIONS: CLINICAL TRIALS OF PULMONARY REHABILITATION
- A9 PRIMARY CILIARY DYSKINESIA IN A GENOMIC THERAPEUTIC ERA
- B101 DECODING DISEASE: BIOMARKERS, PHENOTYPES, AND PRECISION MEDICINE
- B102 ADVANCING COPD DIAGNOSIS, RISK STRATIFICATION, AND PERSONALIZED CARE: FROM BIOMARKERS TO CLINICAL IMPLEMENTATION
- B105 HAKUNA MATATA: STRESS-FREE, NOVEL APPROACHES TO PREDICT, DIAGNOSE, AND MANAGE PEDIATRIC PULMONARY DISEASES
- B108 IMPROVING FUNCTION, STRENGTH AND OUTCOMES THROUGH PULMONARY REHABILITATION
- B109 CELLULAR, GENETIC, AND DEVELOPMENTAL DRIVERS OF COPD, EMPHYSEMA AND SARCOPENIA
- B110 THE NEW FRONTIER IS HERE: AI IN PULMONARY MEDICINE
- B15 PRECISION MEDICINE FOR COPD: CHARTING THE COURSE FOR NOVEL TREATMENTS AND CLINICAL SUCCESS
- B16 FROM SEA TO SHINING SEA: USING NATIONAL DATA TO EXAMINE ASTHMA AND COPD
- B24 INSIGHTS FROM COPD CLINICAL TRIALS
- B27 BREATH OF FRESH AIR: JOURNEY FROM DIAGNOSIS TO RECOVERY IN PULMONARY AND CRITICAL CARE
- B28 MOLECULAR AND CELLULAR DETERMINANTS OF AIRWAY BIOLOGY AND LUNG IMMUNITY
- B29 THE LATEST IN AIRWAY SYMPTOMS AND DISEASE
- B33 UNRAVELING THE OMIC LAYERS: TRANSLATIONAL INSIGHTS IN AIRWAYS DISEASE
- B38 TRAINING THAT TRANSLATES: EDUCATION AND QUALITY IMPROVEMENT IN PULMONARY AND CRITICAL CARE
- B39 BREATH AND BURDEN: DIFFUSE LUNG DISEASES AND DAILY LIFE
- B40 BSHSR LATE-BREAKING ABSTRACTS
- B44 SHARPENING THE COPD LENS: ENHANCED DETECTION AND POPULATION-SPECIFIC CARE
- B56 POLLUTION PUZZLE: CONNECTING EXPOSURE, EDUCATION, AND ACTION
- B58 ASSESSING LUNG HEALTH IN THE REAL WORLD
- B59 RECENT INNOVATIONS IN PULMONARY AND CRITICAL CARE DISEASE MANAGEMENT
- B63 PEDIATRIC INFECTION, AUTOIMMUNITY, AND IMMUNODEFICIENCY: JUNGLE CRUISE
- B6 OMICS TO ACTION: REDESIGNING TRIALS AND CARE IN RESPIRATORY MEDICINE
- B74 PULMONARY REHABILITATION ACROSS DIFFERENT SETTINGS AND DISEASES
- B76 IMMUNE, VASCULAR AND OTHER NEW MECHANISMS IN THE BIOLOGY OF COPD
- B78 STRUCTURAL AND FUNCTIONAL INSIGHT INTO COPD
- B80-1 CASE REPORTS IN LUNG STRUCTURE AND FUNCTION II
- B80-4 CUTTING-EDGE DIAGNOSTICS FOR LUNG CANCER: NEW FRONTIERS IN NODULE RISK STRATIFICATION AND ADVANCED INTERVENTIONAL TOOLS
- B81 NURSING YEAR IN REVIEW: NAVIGATING CARE TRANSITIONS IN PULMONARY, CRITICAL CARE, AND SLEEP
- B85 BEYOND -OMICS: CONNECTING MOLECULAR BIOLOGY TO CELL PATHOPHYSIOLOGY USING SPATIO-TEMPORAL MULTI-MODAL IMAGING
- B86 NEW AND HOT CONCEPTS IN COPD
- B8 PULMONARY REHABILITATION IN NON-COPD PATIENTS: UPDATES ON THE EVIDENCE, CLINICAL INDICATIONS AND PHYSIOLOGY
- B92 ESCALATING USE, EMERGING SCIENCE: VAPE/SMOKE INDUCED LUNG DISEASE
- B94 BEYOND THE EXACERBATION: SYSTEMS, COSTS, AND RECOVERY IN OBSTRUCTIVE LUNG DISEASES
- B97 WHERE THERE’S HEAT, THERE’S (SOMETIMES) FIRE: RESPIRATORY CONSEQUENCES OF A WARMING WORLD
- C101 THE COPD RUBIX CUBE: ‘OMICS AND MECHANISMS
- C102 FROM KNOWING TO DOING: EDUCATING AND IMPLEMENTING EVIDENCE-BASED PULMONARY CARE
- C108 STRUCTURE MEETS FUNCTION: MEASUREMENTS OF THE LUNG
- C10 PULMONARY REHABILITATION AROUND THE WORLD: LEARNING FROM THE FRONTLINES
- C15 MICROBIAL MAESTROS: TOWARDS MECHANISMS OF MICROBIOME INFLUENCE IN LUNG DISEASE
- C16 MARKETS AND MANDATES: HEALTH POLICY AND PULMONARY OUTCOMES
- C19 HOW TO FIX A LUNG: TREATMENT, REPAIR AND REGENERATION AFTER LUNG INJURY
- C20 THE NEXT TOP MODEL: NOVEL LUNG MODELS FOR INVESTIGATING PULMONARY HEALTH AND DISEASE
- C2 IMMUNE ACTIVATION AND FIBROSIS WITHIN THE PULMONARY VASCULAR MICROENVIRONMENT
- C33 FROM DATA TO BREATHS: STORIES OF ASTHMA UNFOLDED
- C35 COPD BEYOND THE CLINIC: CARE, CONTEXT, AND CONSEQUENCES
- C38 LIVING WITH LUNG DISEASE WORLDWIDE: CARE, BURDEN, AND ADAPTATION
- C4 CONTENTIOUS TOPICS IN COPD CARE: A PRO/CON DEBATE
- C59 CASE REPORTS IN ENVIRONMENTAL AND OCCUPATIONAL HEALTH
- C61 CF, PCD, AND NON-CF BRONCHIECTASIS IN CHILDREN: FRONTIERLAND
- C70 FROM EXPOSURE TO THERAPY: TRANSLATIONAL BIOLOGY OF AIRWAY INFLAMMATION AND LUNG INFECTION
- C73 SEEING IS BELIEVING: NEW DEVELOPMENTS IN LUNG IMAGING
- C77 DATA-DRIVEN STRATEGIES IN THORACIC ONCOLOGY: INTEGRATING REAL-WORLD EVIDENCE TO SHAPE LUNG CANCER TREATMENT AND OUTCOMES
- C7 NEW APPROACHES TO THE PATIENT WITH CHRONIC PRODUCTIVE COUGH
- C81 NON-TOBACCO COPD – CLASSIFYING DISEASE, IDENTIFYING EXPOSURES AND CLINICAL TRIAL CONSIDERATIONS
- C85 ATS GUIDELINES AND CLINICAL STATEMENTS: CONTROVERSIES IN RESPIRATORY FAILURE AND ILA/ILD
- C86 VASCULOPATHIES IN PULMONARY DISEASE? THE DARK SIDE OF THE LUNG
- C8 SEEING THE DIFFERENCE: USING IMAGING TO DEFINE COPD SUBGROUPS
- C91 PRIMARY PALLIATIVE CARE IN PULMONARY-CRITICAL CARE MEDICINE: A ‘PALLIPULM’ FRAMEWORK FOR EDUCATION, PRACTICE, AND POLICY
- C94 ONE LUNG, MANY OMICS: HOW ENVIRONMENTAL EXPOSURES SHAPE LUNG BIOLOGY
- C95 EMERGING CLINICAL RESEARCH IN PEDIATRIC PULMONOLOGY: TO INFINITY AND BEYOND
- C97 NOVEL APPROACHES AND UNDERSTANDING TO SKELETAL MUSCLE, REHABILITATION AND ACUTE RECOVERY
- C98 NEW INSIGHTS INTO COPD PATHOGENESIS
- C99 UNRAVELING AIRWAY BIOLOGY: NEW INSIGHTS INTO DISEASE
- D102 METHODS, MEASUREMENT, AND MEANING: CROSS-CUTTING CHALLENGES IN PULMONARY CARE
- D108 EMERGING CONCEPTS IN THE PATHOGENESIS OF COPD AND LUNG CANCER
- D109 NOVEL INSIGHTS INTO PULMONARY VASCULAR DISEASES
- D110 DIAGNOSTIC DILEMMAS AND RARE ENTITIES IN THORACIC ONCOLOGY: LESSONS FROM COMPLEX CASES
- D12 INEQUITIES BY DESIGN: SOCIAL AND STRUCTURAL DRIVERS OF PULMONARY HEALTH
- D15 BE OUR GUEST: EXPLORING CUTTING-EDGE BPD RESEARCH
- D18 ENVIRONMENTAL AND CELLULAR STRESSORS SHAPING LUNG BIOLOGY, IMMUNITY AND DISEASE
- D19 THE NEXT GENERATION: NOVEL TARGETS AND THERAPIES FOR CHRONIC LUNG DISEASE
- D22 FROM SCREENING TO SURVIVAL: UNEQUAL PATHS IN PULMONARY CARE
- D26 THE UNINTENDED CONSEQUENCES: ENVIRONMENTAL IMPACTS OF AIR POLLUTION, CLIMATE CHANGE, AND MODERN LUNG DISEASE TREATMENT
- D27 MIRROR, MIRROR ON THE WALL: WHO HAS THE BEST PEDIATRIC PULMONARY CASE OF ALL?
- D2 A TALE OF TWO TRANSPLANTS: THE CONVERGENT PATHS OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION AND PULMONARY GRAFT VERSUS HOST DISEASE
- D30 DIVING DEEPER INTO COPD STRUCTURE AND FUNCTION
- D5 EMPHYSEMA DECODED: AGING GONE WRONG OR REPAIR GONE MISSING?
- D83 EARTH, WIND, AND FIRE: TRANSLATIONAL LESSONS FROM A CHANGING PULMONARY (MICRO)ENVIRONMENT
- D84 EAT. KILL. SURVIVE. THE MACROPHAGE-NTM STANDOFF
- D86 LOCATION, LOCATION, LOCATION: INTERCELLULAR COMMUNICATION DRIVING LUNG DISEASE
- D91 INFECTION, IMMUNITY, INTERVENTIONS: VIRUSES, BACTERIA, AND BRONCHIECTASIS OUTCOMES
- D92 NEW THERAPEUTICS, INTERVENTIONS, AND MONITORING IN CHRONIC RESPIRATORY DISEASE
- D96 STICKY SITUATIONS: MUCUS PLUGGING IN PULMONARY DISEASE
- Early Insults and Lung Trajectories
- MD11 STUDY UPDATES FROM THE AMERICAN LUNG ASSOCIATION’S AIRWAY CLINICAL RESEARCH CENTERS NETWORK
- MD13 RED JOURNAL IN ACTION 2: LUNG REPAIR MODELS AND MECHANISMS
- MD16 USING NASA SATELLITE DATA TO GUIDE NOVEL AIR QUALITY APPLICATIONS
- MD18 NEW RESULTS FROM THE SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD STUDY (SPIROMICS ) FAMILY OF STUDIES
- MD19 PULMONARY UPDATE FROM THE US FOOD AND DRUG ADMINISTRATION
- MD1 RED JOURNAL IN ACTION 1: EARLY CAREER LUNG RESEARCH HIGHLIGHTS
- MD20 LEVERAGE HUMAN-BASED APPROACHES TO STUDY LUNG RESILIENCE AND DISEASE
- MD24 LUNGMAP PHASE 3- NOVEL TECHNOLOGY, DATA SCIENCE, AND RESOURCES
- MD26 LUNG MAP PHASE 3- HIGH RESOLUTION MOLECULAR PROFILING OF LUNG DISEASES
- MD29 COPD UNDERSTANDING COPD PROGRESSION AND HETEROGENEITY
- MD6 VHA LUNG PRECISION ONCOLOGY PROGRAM: KEY FINDINGS FROM SCREENING RESEARCH
- MD7 ENVIRONMENTAL EXPOSURES AND CHRONIC PULMONARY MORBIDITY
- MD9 GENERIC DRUG DEVELOPMENT FOR RESPIRATORY PRODUCTS, US FOOD AND DRUG ADMINISTRATION UPDATE
- MTE11 SELECTION AND MANAGEMENT OF “HIGH RISK” LUNG TRANSPLANT CANDIDATES
- MTE15 POTENTIAL AND PITFALLS OF AI FOR CLINICIANS AND EDUCATORS
- MTE17 COPD AND HOMEBASED NIV — INTRODUCTION TO THE NEW CMS COVERAGE DETERMINATION
- MTE29 UPDATED BRONCHIECTASIS GUIDELINES: INTEGRATING INTO CLINICAL PRACTICE
- MTE30 MAKING WAVES: OSCILLOMETRY BASICS AND INTERPRETATION FOR CLINICAL AND RESEARCH APPLICATION
- MTE37 THE CELLULAR LANDSCAPE OF COPD: NOVEL INSIGHTS FROM GENOMICS AND CELL BIOLOGY
- MTE4 SMALL BUT MIGHTY-EVS IN LUNG HEALTH AND DISEASE
- MTE5 BRONCHIECTASIS: A SILENT STORM BEHIND THE COUGH
- MTE8 ADVANCING PULMONARY REHAB: RESPIRATORY MUSCLE TRAINING ACROSS CARE SETTINGS
- PCC2 PEDIATRIC CLINICAL CORE CURRICULUM
- PCC3 PEDIATRIC CLINICAL CORE CURRICULUM
- PG14 CARDIOPULMONARY EXERCISE TESTING: ADVANCES AND APPLICATIONS
- PG15 ASTHMA AND BEYOND: MOLECULAR MECHANISMS, PHYSIOLOGY, AND TREATMENT
- PG1A TAKE IT ALL IN!: COMPREHENSIVE REVIEW OF PEDIATRIC PULMONOLOGY AND PREPARATION FOR THE BOARDS
- PG1B TAKE IT ALL IN!: COMPREHENSIVE REVIEW OF PEDIATRIC PULMONOLOGY AND PREPARATION FOR THE BOARDS
- PG21 TRANSLATIONAL WINDOWS INTO THE LUNG MICROENVIRONMENT: ADVANCES WITH PRECISION-CUT LUNG SLICES
- PG3 BRONCH DAY 2026: A COMPREHENSIVE, HANDS-ON GUIDE TO BASIC BRONCHOSCOPY, EBUS, AND GUIDED BRONCHOSCOPY
- PG6 BEST PRACTICES IN PULMONARY FUNCTION TESTING
- PG7 COPD 2026: STATE OF THE ART
- PG8 BRONCHIECTASIS AND NTM PULMONARY DISEASE: ETIOLOGIES, COMPLEX CASE MANAGEMENT, AND UPDATED GUIDELINES
- Respiratory Innovation Summit
- Roadmap to Clean Air and Healthier Lungs
- SPS SCALING EVIDENCE-BASED PRACTICE WITHIN LARGE HEALTHCARE NETWORKS
- The Underrecognized Burden of Asthma in Low and Middle-Income Countries
Don’t Miss the ATS 2026 International Conference
Register today for the ATS 2026 International Conference to experience this year’s premier respiratory health conference, May 15-20 in Orlando. Join your colleagues to learn about the latest developments in pulmonary, critical care, and sleep medicine.
Not an ATS member? Join today and save on your conference registration!